FAM
INSY

Foundation Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Foundation Asset Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-470,390
Closed -$9.12M – 32
2014
Q3 		$9.12M Buy
470,390
+321,200
+215% +$5.04M 2.5% 15
2014
Q2 		$2.33M Buy
+149,190
New +$2.41M 0.67% 15

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Foundation Asset Management's INSY Position: Q4 2014 in Review

Foundation Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q4 2014, closing a stake of 470,390 shares — an estimated $9.12M sold.

Foundation Asset Management first reported a position in INSY in Q2 2014 and held it in 2 quarters. The position peaked at $9.12M in Q3 2014. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2014.

  • Foundation Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q4 2014 after selling out during the quarter.
  • Foundation Asset Management sold 470,390 Insys Therapeutics, Inc. shares in Q4 2014, an estimated $9.12M.
  • Foundation Asset Management first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 2 quarters.
  • Foundation Asset Management's Insys Therapeutics, Inc. position peaked at $9.12M in Q3 2014.
  • 113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2014.

Based on Foundation Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.